OrthoPediatrics Corp. (NASDAQ:KIDS) Short Interest Update

OrthoPediatrics Corp. (NASDAQ:KIDSGet Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 801,100 shares, a decline of 12.3% from the October 31st total of 913,900 shares. Based on an average daily trading volume, of 162,600 shares, the short-interest ratio is currently 4.9 days. Currently, 4.9% of the shares of the stock are short sold.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in KIDS. Vanguard Group Inc. raised its position in OrthoPediatrics by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 883,827 shares of the company’s stock worth $25,772,000 after purchasing an additional 11,100 shares during the last quarter. Harbor Capital Advisors Inc. boosted its holdings in OrthoPediatrics by 649.0% in the second quarter. Harbor Capital Advisors Inc. now owns 67,057 shares of the company’s stock valued at $1,929,000 after acquiring an additional 58,104 shares during the last quarter. SG Americas Securities LLC acquired a new stake in OrthoPediatrics during the 2nd quarter valued at approximately $110,000. Bank of New York Mellon Corp raised its holdings in OrthoPediatrics by 14.9% during the 2nd quarter. Bank of New York Mellon Corp now owns 68,700 shares of the company’s stock worth $1,976,000 after purchasing an additional 8,887 shares during the last quarter. Finally, Commonwealth Equity Services LLC raised its stake in OrthoPediatrics by 0.6% during the second quarter. Commonwealth Equity Services LLC now owns 72,935 shares of the company’s stock worth $2,098,000 after buying an additional 420 shares during the last quarter. Institutional investors own 69.05% of the company’s stock.

OrthoPediatrics Stock Performance

OrthoPediatrics stock traded up $0.59 during trading hours on Friday, hitting $25.98. The stock had a trading volume of 73,343 shares, compared to its average volume of 202,861. The business’s 50 day simple moving average is $26.04 and its 200-day simple moving average is $29.10. OrthoPediatrics has a one year low of $22.41 and a one year high of $36.23. The company has a debt-to-equity ratio of 0.19, a current ratio of 7.17 and a quick ratio of 3.68.

Analyst Upgrades and Downgrades

KIDS has been the subject of several research analyst reports. Truist Financial lowered their target price on OrthoPediatrics from $34.00 to $28.00 and set a “hold” rating for the company in a research note on Monday, October 14th. JMP Securities reiterated a “market outperform” rating and set a $50.00 price objective on shares of OrthoPediatrics in a research report on Friday, September 13th. Finally, Needham & Company LLC restated a “buy” rating and issued a $42.00 target price on shares of OrthoPediatrics in a research report on Friday, November 8th.

Check Out Our Latest Analysis on OrthoPediatrics

About OrthoPediatrics

(Get Free Report)

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.

Featured Stories

Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.